Curasight A/S reports positive preclinical results with uTREAT® in aggressive brain cancer (glioblastoma)
Curasight A/S is pleased to announce preclinical data demonstrating the effectiveness of uTREAT® in treating aggressive brain cancer.
Uncategorized
D&A Pharma: New confirmation for sodium oxybate in the treatment of alcohol dependence: a university thesis provides new evidence and explains its efficacy in maintaining abstinence
While several effective treatments are currently available for the treatment of alcohol withdrawal syndrome, there is an unmet medical need in the abstinence maintenance phase.
Axol Bioscience Collaborates With StrataStem to Deliver Stem Cell Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
Axol Bioscience Ltd., a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s Disease patient samples.
Baterías en sistemas fotovoltaicos: Analizando los beneficios e inconvenientes para el hogar
Con el creciente interés en la energía solar y la adopción de sistemas fotovoltaicos en los hogares, surge la pregunta de si incorporar baterías en estos sistemas es una opción viable. Las baterías de almacenamiento de energía ofrecen la posibilidad d …
Las erupciones solares propiciaron el inicio de la vida en la Tierra
En este Short examinaremos en qué medida las erupciones solares pudieron contribuir a la aparición de la vida en la Tierra primitiva. …
Las erupciones solares propiciaron el inicio de la vida en la Tierra Read More »
XNK Therapeutics appoints Hugo Petit as Chief Financial Officer
XNK Therapeutics announced the appointment of Hugo Petit as Chief Financial Officer and member of the company’s leadership team.
XNK Therapeutics appoints Hugo Petit as Chief Financial Officer Read More »
ImmVira presented latest encouraging clinical results of two proprietary products at ASCO 2023
ImmVira submitted four abstracts covering latest results from Phase I/II clinical trials of MVR-T3011 IT and MVR-T3011 IV in both U.S. and China with all selected to be published at the 2023 American Society for Clinical Oncology Annual Meeting taking place from June 2nd to 6th, 2023 in Chicago, IL.
InfiRay® Debuts at WIN EURASIA 2023
IRay Technology Co., Ltd., a leading brand in the thermal imaging industry, has shown itself with a high profile at WIN EURASIA 2023 in Istanbul.
Cellusion raises 2.83 Billion Yen (21 Million USD) in Series C Round
Cellusion Inc. announced that it has raised 2.83 billion yen in Series C Round financing.
Cellusion raises 2.83 Billion Yen (21 Million USD) in Series C Round Read More »
CymaBay Therapeutics to Present New Data Highlighting Seladelpar’s Unique Activity in Patients with Primary Biliary Cholangitis at The International Liver Congress™ 2023
CymaBay Therapeutics, Inc. announced it will make three presentations at the European Association for the Study of the Liver ‘s The International Liver Congress™ 2023.